| Company Name: | National Dentex Corporation | | Ticker Symbol: | NADX | | | WWW Address: | www.nadx.com | | CEO: | David L. Brown | | No. of Employees: | 1,981 | | Common Issue Type: | CS | | Business Description: | The Company is engaged in the business of designing, fabricating, marketing and selling of custom dental prosthetic appliances.
|
| | | Industry Information: | HEALTH SERVICES - Medical Laboratories & Research [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 8.41 |  0.41 | 7.25 | 8.5 | 8.0 | 8.45 | 8.00 | 4994 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 48.8 | 5.8 | 1.73 | -0.16 | 0.00 | 0.0 | 0.0 | 8.93 - 1.25 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 8.00 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 46.1 | mil |
| Latest Shares Outstanding | 5.8 | mil |
| Earnings pS (EPS) | -0.16 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 86,660 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 5.5 | mil |
| Float as % of Shares Outstanding | 95.6 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 34.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 45.4 | % |
| EBITDA Margin | 11.3 | % |
| Pre-Tax Profit Margin | 1.7 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | 0.1 | % |
| Return on Equity (ROE) | 0.2 | % |
| Return on Capital Invested (ROCI) | 0.1 | % |
| Current Ratio | 1.4 | |
| Leverage Ratio (Assets/Equity) | 1.6 | |
| Interest Cover | 2.8 | |
| Total Debt/Equity (Gearing Ratio) | 0.28 | |
| LT Debt/Total Capital | 19.0 | % |
| Working Capital pS | 1.41 | $ |
| Cash pS | 0.23 | $ |
| Book-Value pS | 16.89 | $ |
| Tangible Book-Value pS | 2.13 | $ |
| Cash Flow pS | 1.10 | $ |
| Free Cash Flow pS | 2.69 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.47 | |
| Price/Tangible Book Ratio | 3.75 | |
| Price/Cash Flow | 7.3 | |
| Price/Free Cash Flow | 3.0 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 3.9 | 103 | 38 | 120 |
| 4 Weeks | 8.45 | 7.01 | 8.00 | 0.0 | 94 | 51 | 867 |
| 13 Weeks | 8.59 | 7.01 | 7.46 | 7.2 | 100 | 36 | 2,171 |
| 26 Weeks | 8.93 | 6.25 | 7.90 | 1.3 | 84 | 77 | 9,563 |
| 52 Weeks | 8.93 | 1.25 | 4.85 | 64.9 | 134 | 105 | 26,024 |
| YTD | 8.93 | 1.25 | - | 75.8 | 144 | 108 | 24,601 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 7.81 | 7.62 | 7.96 | 7.42 | 6.32 | 1.73 | 1.80 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 8.72 | 82.5 | 3.75 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 8.13 | NA | -26.30 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -5.7 | -7.8 | 0.8 |
| Earnings % | 23.6 | 33.8 | -100.0 |
| EPS % | 21.8 | 28.6 | -100.0 |
| EPS $ | 0.17 | 0.04 | -1.33 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 5.90 |
| Current Ratio | 1.4 |
| Quick Ratio (Acid Test) | 0.9 |
| Liquidity Ratio (Cash) | 0.09 |
| Receivables Turnover | 9.1 |
| Average Collection Period | 40 |
| Working Capital/Equity | 10.5 |
| Working Capital pS | 1.68 |
| Cash-Flow pS | 0.91 |
| Free Cash-Flow pS | -0.65 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.62 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 44.0 |
| Total Debt/Equity (Gearing Ratio) | 0.47 |
| LT Debt/Equity | 0.38 |
| LT Debt/Capital Invested | 38.1 |
| LT Debt/Total Liabilities | 48.1 |
| Interest Cover | 1.5 |
| Interest/Capital Invested | 1.53 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 19.28 |
| Tobin's Q Ratio | 0.29 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 6.80 |
| Enterprise Value (EV)/Free Cash Flow | -58.33 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.75 |
| Price/Book Ratio - LTM | 0.47 |
| Price/Cash Flow Ratio | 7.3 |
| Price/Free Cash Flow Ratio - LTM | 3.0 |
| Price/Sales Ratio | 0.28 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 5.4 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 6.03 |
| Current Liabilities pS | 4.15 |
| Tangible Book Value pS - LTM | 2.13 |
| Book Value pS - LTM | 16.89 |
| Capital Invested pS | 21.67 |
| Cash pS - LTM | 0.23 |
| Cash Flow pS - LTM | 1.10 |
| Free Cash Flow pS - LTM | 2.69 |
| Earnings pS (EPS) | -0.16 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -2.15 |
| Free Cash Flow Margin 5YEAR AVG | -4.37 |
| Net Profit Margin | -0.5 |
| Net Profit Margin - 5YEAR AVRG. | 3.2 |
| Equity Productivity | 1.90 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 5.8 |
| Capital Invested Productivity | 1.38 |
| Return on Capital Invested (ROCI) | -0.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 4.6 |
| Assets Productivity | 1.10 |
| Return on Assets (ROA) | -0.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | 3.6 |
| Gross Profit Margin | 45.4 |
| Gross Profit Margin - 5YEAR AVRG. | 44.5 |
| EBITDA Margin - LTM | 11.3 |
| EBIT Margin - LTM | 2.7 |
| Pre-Tax Profit Margin | 0.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 5.5 |
| Effective Tax Rate | 180.1 |
| Effective Tax Rate - 5YEAR AVRG. | 66.8 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 67 |
| Revenue per Employee | 86,660 |
| Net Income per Employee | -443 |
| Average Collection Period | 40 |
| Receivables Turnover | 9.1 |
| Day's Inventory Turnover Ratio | 27 |
| Inventory Turnover | 13.4 |
| Inventory/Sales | 4.1 |
| Accounts Payble/Sales | 2.06 |
| Assets/Revenue | 0.91 |
| Net Working Capital Turnover | 18.02 |
| Fixed Assets Turnover | 1.34 |
| Total Assets Turnover | 1.1 |
| Revenue per $ Cash | 81.36 |
| Revenue per $ Plant | 5.13 |
| Revenue per $ Common Equity | 1.90 |
| Revenue per $ Capital Invested | 1.38 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 34.1 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 33.5 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |